Feasibility of eradication of breast cancer cells remaining in postlumpectomy cavity and draining lymph nodes following intracavitary injection of radioactive immunoliposomes

Molecular Pharmaceutics

Volumn 9, Issue 9, 2012, Pages 2513-2522

  Li, Shihong ^a   Goins, Beth ^a   Hrycushko, Brian A ^a   Phillips, William T ^a   Bao, Ande ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

breast cancer; immunoliposomes; intracavitary injection; metastasis; targeted therapy

Indexed keywords

BEVACIZUMAB; IMMUNOLIPOSOME; PANITUMUMAB; RHENIUM 186; RHENIUM 188; TECHNETIUM 99M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CONTROL; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; LYMPH NODE; LYMPHATIC DRAINAGE; MOUSE; NONHUMAN; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; IMMUNOTOXINS; LIPOSOMES; LYMPH NODES; MAMMARY NEOPLASMS, EXPERIMENTAL; MASTECTOMY, SEGMENTAL; PARTICLE SIZE; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, NUDE; RHENIUM; TECHNETIUM;

EID: 84865985491     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300132f     Document Type: Article

References (50)

1. Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N. Engl. J. Med. 1995, 333, 1444-1455.
2. Forrest, A. P.; Stewart, H. J.; Everington, D.; Prescott, R. J.; McArdle, C. S.; Harnett, A. N.; Smith, D. C.; George, W. D. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial Scottish Cancer Trials Breast Group Lancet 1996, 348, 708-713 (Pubitemid 26302305)
3. Liljegren, G.; Holmberg, L.; Bergh, J.; Lindgren, A.; Tabar, L.; Nordgren, H.; Adami, H. O. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial J. Clin. Oncol. 1999, 17, 2326-2333 (Pubitemid 29368230)
4. Van de Steene, J.; Vinh-Hung, V.; Cutuli, B.; Storme, G. Adjuvant radiotherapy for breast cancer: effects of longer follow-up Radiother. Oncol. 2004, 72, 35-43 (Pubitemid 38952857)
5. Veronesi, U.; Marubini, E.; Mariani, L.; Galimberti, V.; Luini, A.; Veronesi, P.; Salvadori, B.; Zucali, R. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial Ann. Oncol. 2001, 12, 997-1003 (Pubitemid 32725776)
6. Sharma, G.; Anabousi, S.; Ehrhardt, C.; Ravi Kumar, M. N. Liposomes as targeted drug delivery systems in the treatment of breast cancer J. Drug Targeting 2006, 14, 301-310 (Pubitemid 44173296)
7. Elbayoumi, T. A.; Torchilin, V. P. Current trends in liposome research Methods Mol. Biol. 2010, 605, 1-27
8. Harrington, K. J.; Rowlinson-Busza, G.; Syrigos, K. N.; Uster, P. S.; Vile, R. G.; Stewart, J. S. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery Clin. Cancer Res. 2000, 6, 2528-2537 (Pubitemid 30399225)
9. Bao, A.; Phillips, W. T.; Goins, B.; Zheng, X.; Sabour, S.; Natarajan, M.; Ross, W. F.; Zavaleta, C.; Otto, R. A. Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection Int. J. Pharm. 2006, 316, 162-169 (Pubitemid 43765700)
10. 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model Clin. Cancer Res. 2008, 14, 3975-3983
11. French, J. T.; Goins, B.; Saenz, M.; Li, S.; Garcia-Rojas, X.; Phillips, W. T.; Otto, R. A.; Bao, A. Interventional therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide J. Vasc. Interv. Radiol. 2010, 21, 1271-1279
12. 99mTc-encapsulated liposomes in nude rats with breast cancer xenograft Breast Cancer Res. Treat. 2011, 130, 97-107
13. Osborne, M. P.; Richardson, V. J.; Jeyasingh, K.; Ryman, B. E. Radionuclide-labelled liposomes-a new lymph node imaging agent Int. J. Nucl. Med. Biol. 1979, 6, 75-83 (Pubitemid 10225538)
14. 14C]adriamycin following intraperitoneal administration to rats Cancer Res. 1981, 41, 1311-1317 (Pubitemid 11146757)
15. Mangat, S.; Patel, H. M. Lymph node localization of nonspecific antibody-coated liposomes Life Sci. 1985, 36, 1917-1925 (Pubitemid 15113252)
16. Oussoren, C.; Storm, G. Liposomes to target the lymphatics by subcutaneous administration Adv. Drug Delivery Rev. 2001, 50, 143-156 (Pubitemid 32727280)
17. Moghimi, M.; Moghimi, S. M. Lymphatic targeting of immuno-PEG-liposomes: evaluation of antibody-coupling procedures on lymph node macrophage uptake J. Drug Targeting 2008, 16, 586-590
18. Phillips, W. T.; Goins, B. A.; Bao, A. Radioactive liposomes Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009, 1, 69-83
19. Hrycushko, B. A.; Li, S.; Shi, C.; Goins, B.; Liu, Y.; Phillips, W. T.; Otto, P. M.; Bao, A. Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes Int. J. Radiat. Oncol. Biol. Phys. 2011, 79, 948-955
20. Harari, P. M. Epidermal growth factor receptor inhibition strategies in oncology Endocr. Relat. Cancer 2004, 11, 689-708 (Pubitemid 40065545)
21. Baselga, J.; Arteaga, C. L. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer J. Clin. Oncol. 2005, 23, 2445-2459 (Pubitemid 47050835)
22. Johnston, J. B.; Navaratnam, S.; Pitz, M. W.; Maniate, J. M.; Wiechec, E.; Baust, H.; Gingerich, J.; Skliris, G. P.; Murphy, L. C.; Los, M. Targeting the EGFR pathway for cancer therapy Curr. Med. Chem. 2006, 13, 3483-3492 (Pubitemid 44873742)
23. Yang, X. D.; Jia, X. C.; Corvalan, J. R.; Wang, P.; Davis, C. G. Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy Crit. Rev. Oncol. Hematol. 2001, 38, 17-23 (Pubitemid 32194591)
24. Folkman, J. Angiogenesis in cancer,vascular, rheumatoid and other disease Nat. Med. 1995, 1, 27-31
25. Kim, K. J.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.; Phillips, H. S.; Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature 1993, 362, 841-844 (Pubitemid 23132159)
26. Ferrara, N.; Gerber, H. P.; LeCouter, J. The biology of VEGF and its receptors Nat. Med. 2003, 9, 669-676 (Pubitemid 36749215)
27. Hsu, J. Y.; Wakelee, H. A. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy BioDrugs 2009, 23, 289-304
28. Ferrara, N.; Hillan, K. J.; Gerber, H. P.; Novotny, W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat. Rev. Drug Discovery 2004, 3, 391-400 (Pubitemid 38618122)
29. Hurwitz, H.; Fehrenbacher, L.; Novotny, W.; Cartwright, T.; Hainsworth, J.; Heim, W.; Berlin, J.; Baron, A.; Griffing, S.; Holmgren, E.; Ferrara, N.; Fyfe, G.; Rogers, B.; Ross, R.; Kabbinavar, F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N. Engl. J. Med. 2004, 350, 2335-2342 (Pubitemid 38702844)
30. Miller, K.; Wang, M.; Gralow, J.; Dickler, M.; Cobleigh, M.; Perez, E. A.; Shenkier, T.; Cella, D.; Davidson, N. E. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer N. Engl. J. Med. 2007, 357, 2666-2676
31. 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies J. Pharmacol. Exp. Ther. 2004, 308, 419-425 (Pubitemid 38134199)
32. Goins, B.; Bao, A.; Phillips, W. T. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy Methods Mol. Biol. 2010, 606, 469-491
33. 99mTc-BMEDA and its stability evaluation: effects of lipid formulation and pH/chemical gradient J. Liposome Res. 2011, 21, 17-27
34. Allen, T. M.; Sapra, P.; Moase, E. Use of the post-insertion method for the formation of ligand-coupled liposomes Cell. Mol. Biol. Lett. 2002, 7, 889-894 (Pubitemid 35334380)
35. Moreira, J. N.; Ishida, T.; Gaspar, R.; Allen, T. M. Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity Pharm. Res. 2002, 19, 265-269 (Pubitemid 34211842)
36. Bohl Kullberg, E.; Bergstrand, N.; Carlsson, J.; Edwards, K.; Johnsson, M.; Sjöberg, S.; Gedda, L. Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents Bioconjugate Chem. 2002, 13, 737-743 (Pubitemid 34801115)
37. Hermanson, G. T. Bioconjugate Techniques; Elsevier: San Diego, CA, 1996; pp 139-140.
38. Elbayoumi, T. A.; Torchilin, V. P. Enhanced accumulation of long-circulating liposomes modifiedwith the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 1196-1205 (Pubitemid 44484476)
39. Chonn, A.; Semple, S. C.; Cullis, P. R. Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo Biochim. Biophys. Acta 1991, 1070, 215-222
40. Bandyopadhyay, A.; Wang, L.; Chin, S. H.; Sun, L. Z. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines Neoplasia 2007, 9, 113-118
41. Huang, C.; Mason, J. T. Geometric packing constraints in egg phosphatidylcholine vesicles Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 308-310 (Pubitemid 8290789)
42. Newman, G. C.; Huang, C. Structural studies on phophatidylcholine- cholesterol mixed vesicles Biochemistry 1975, 14, 3363-3370
43. 186Re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response Cancer Biother. Radiopharm. 2011, 26, 603-614
44. 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model Radiology 2011, 261, 813-823
45. Mannino, M.; Yarnold, J. Effect of breast-duct anatomy and wound-healing responses on local tumour recurrence after primary surgery for early breast cancer Lancet Oncol. 2009, 10, 425-429
46. Gonzalez, E. A.; Saltzstein, E. C.; Riedner, C. S.; Nelson, B. K. Seroma formation following breast cancer surgery Breast J. 2003, 9, 385-388 (Pubitemid 37158912)
47. Kuroi, K.; Shimozuma, K.; Taguchi, T.; Imai, H.; Yamashiro, H.; Ohsumi, S.; Saito, S. Pathophysiology of seroma in breast cancer Breast Cancer 2005, 12, 288-293
48. Stacker, S. A.; Achen, M. G.; Jussila, L.; Baldwin, M. E.; Alitalo, K. Lymphangiogenesis and cancer metastasis Nat. Rev. Cancer 2002, 2, 573-583 (Pubitemid 37328924)
49. Sleeman, J.; Schmid, A.; Thiele, W. Tumor lymphatics Semin. Cancer Biol. 2009, 19, 285-297
50. Matsui, J.; Funahashi, Y.; Uenaka, T.; Watanabe, T.; Tsuruoka, A.; Asada, M. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase Clin. Cancer Res. 2008, 14, 5459-5465